[5] 王勤，楊亦彬. 肠道菌群失调对糖尿病及糖尿病肾病影响的研究进展[J]. 医学综述，2019，3：530-534.

    [6] Grasset E，Burcelin R. The gut microbiota to the brain axis in the metabolic control[J]. Reviews in Endocrine & Metabolic Disorders，2019，20(4)：427-430.

    [7] 李雷，杨云梅，吴月，老年2型糖尿病患者肠道菌群多样性及其炎症因子与胰岛素抵抗的相关性研究[J]. 中华危重症医学杂志(电子版)，2018，5：316-321.

    [8] Davies MJ，Bain SC，Atkin SL，et al，Efficacy and Safety of Liraglutide Versus Placebo as Add-on to Glucose-Lowering Therapy in Patients With Type 2 Diabetes and Moderate Renal Impairment(LIRA-RENAL)：A Randomized Clinical Trial[J]. Diabetes Care ......